missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30173494

CD47 Antibody (974222) [Janelia Fluor™ 585], Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals FAB18661JF585

Product Code. 30173494

  • 531.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD47 Monoclonal antibody specifically detects CD47 in Mouse samples. It is validated for Flow Cytometry,Blockade of Receptor-ligand Interaction,CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD47
Monoclonal
Janelia Fluor 585
antigen identified by monoclonal 1D8, Antigenic surface determinant protein OA3, CD47 antigen, CD47 antigen (Rh-related antigen, integrin-associated signal transducer), CD47 glycoprotein, CD47 molecule, IAPintegrin associated protein, Integrin-associated protein, leukocyte surface antigen CD47, MER6integrin-associated signal transducer, OA3, Protein MER6, Rh-related antigen
Mouse myeloma cell line NS0-derived mouse CD47, Gln19-Pro158, Accession # NP_034711
0.1 mL
Immunology, Signal Transduction
961
Store at 4°C in the dark.
IgG1
Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF
974222
50mM Sodium Borate
Rat
Protein A or G purified
RUO
Primary
Mouse
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.